Actions
Pages
Subscribe for newsletter
Stories
Forge Nano Inc, a leading materials science company, launched a new $165 million lithium-ion battery manufacturing business in Raleigh, NC called Forge Battery. The Gigafactory will produce Atomic Armor surface technology coated lithium-ion cells suitable for defense, aerospace and specialty EVs.
The new Gigafactory bolsters the U.S. battery supply chain and job market, reducing global reliance on foreign suppliers.
“We are extremely excited to launch Forge Battery in the Battery Belt, where we intend to produce batteries for the world’s most demanding applications, while showcasing the power of Forge Nano’s Atomic Armor coating equipment in a large-scale manufacturing environment,” says Paul Lichty, CEO of Forge Nano.
Forge Battery is set to hold a groundbreaking event in early 2024, positioning Raleigh as a key hub in the emerging Battery Belt.
Story
The European Commission launches its first-ever European Hydrogen Bank auction with €800 million to ramp up the European production of renewable hydrogen. This move aims to close the cost gap between production and consumer prices, making renewable hydrogen more competitive in the market.
The growth of the market for renewable hydrogen plays a critical role in Europe’s future energy mix. It is a major stride in Europe’s pursuit of carbon reduction and targeting key sectors such as heavy industry and transport by replacing fossil fuels. It introduces “Auctions-as-a-service”, allowing Member States to finance projects that were not selected for Innovation Fund support, reducing administrative burdens and costs.
“We are investing massively in this transition by using the revenues of emissions trading. This is a sustainable model that brings down emissions and boosts the competitiveness of European industry,” said the EU’s new Green Deal chief, Maroš Šefčovič.
The focus now shifts to the successful implementation of the auction system and monitoring its impact on hydrogen production costs. A second round of auctions in 2024 indicates the EU's commitment to ongoing support for this burgeoning sector.
The pilot auction contrasts with the approaches of other nations and we will see whether Europe can establish a lead in this crucial sector.
Story
Vivodyne, a biotech research startup, has announced $38 million in funding led by Khosla Ventures. Vivodyne leverages AI-scale testing on lab-grown human organs for preclinical testing for every stage of drug development.
Vivodyne enables their biopharma partners to see human data even before clinical trials and reduces the need for animal testing. Their platform can mimic drug interactions with human cells offering more precise results, enhance drug success rates and accelerate the discovery of more effective treatments.
“We’re thrilled to have Khosla Ventures lead this funding round, which accelerates the development of our AI platform that enables the generation of predictive human data before therapeutics enter clinical trials,” said Andrei Georgescu, CEO and Co-Founder of Vivodyne.
Vivodyne plans to expand its platform and potentially collaborate with top biopharma companies. This expansion aims to advance AI-driven drug discovery using its extensive human data sets.
Story
Innovators
Scroll
Open
Close